GlaxoSmithKline traded at 1,793.00 this Wednesday June 29th, increasing 27.00 or 1.53 percent since the previous trading session. Looking back, over the last four weeks, GlaxoSmithKline gained 3.76 percent. Over the last 12 months, its price rose by 26.32 percent. Looking ahead, we forecast GlaxoSmithKline to be priced at 1,709.13 by the end of this quarter and at 1,575.37 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 154.14 1.65 1.08% 36.84%
Alcon AG 66.04 -0.40 -0.60% 1.95%
Almirall SA 10.63 -0.03 -0.28% -27.74%
Amgen 245.43 1.92 0.79% 0.69%
argenx SE 352.50 6.20 1.79% 38.18%
Artemis Alpha 299.50 -4.50 -1.48% -32.85%
AstraZeneca 11,054.00 268.00 2.48% 27.31%
Bayer 57.62 -2.61 -4.33% 12.52%
Biogen 205.23 2.72 1.34% -40.73%
Bristol-Myers Squibb 78.28 -0.42 -0.53% 17.15%
Fresenius Medical Care 48.01 0.21 0.44% -31.45%
Fresenius 29.14 0.16 0.55% -33.77%
Genmab 2,259.00 17.00 0.76% -11.96%
Gilead Sciences 62.48 0.27 0.43% -9.27%
Galapagos 52.82 -0.40 -0.75% -9.68%
GRIFOLS 16.99 -2.39 -12.33% -25.61%
GlaxoSmithKline 1,793.00 27.00 1.53% 26.32%
Hikma Pharmaceutical 1,645.50 -32.00 -1.91% -32.73%
Eli Lilly 323.00 5.38 1.69% 40.73%
Lonza Group 502.40 -9.20 -1.80% -23.39%
Merck 160.80 -2.90 -1.77% -0.56%
Merck & Co 92.51 0.62 0.67% 18.95%
Novartis 81.19 0.05 0.06% -3.71%
Orion 41.34 1.63 4.10% 14.04%
Pfizer 50.94 0.28 0.55% 30.08%
Philips 20.45 -0.02 -0.07% -51.06%
Recordati 41.47 0.29 0.70% -13.96%
Regeneron Pharmaceuticals 597.62 3.20 0.54% 4.00%
Roche Holding 319.65 2.10 0.66% -8.29%
Sanofi 100.88 1.51 1.52% 14.17%
Smith & Nephew PLC 1,159.00 -5.50 -0.47% -25.82%
UCB 82.12 0.60 0.74% -6.85%

Indexes Price Day Year
GB100 7312 -11.09 -0.15% 3.91%

GlaxoSmithKline
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.